ImClone Systems Incorporated Says Bristol-Myers Squibb Company (JOBS) Bid is ‘Substantially’ Too Low

NEW YORK (MarketWatch) -- ImClone Systems Inc said Monday it is forming a committee to study the $4.5 billion offer it received from Bristol-Myers, but its board's preliminary view is that the offer substantially undervalues ImClone.